Eledon Pharmaceuticals (ELDN) Interest Expenses (2013 - 2026)
Eledon Pharmaceuticals (ELDN) posted Interest Expenses of $100000.0 for Q1 2026, up 1.01% on a QoQ basis from $99000.0 in Q4 2025, and down 89.9% year-over-year from $990000.0 in Q1 2025.
Eledon Pharmaceuticals (ELDN) Interest Expenses (2013 - 2026) Analysis & Trends
Eledon Pharmaceuticals' Interest Expenses history runs 14 years deep, the most recent figure standing at $100000.0 for Q1 2026.
- Quarterly Interest Expenses fell 89.9% year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $404000.0 (down 59.19% YoY) and the FY2025 annual result came in at $63.0 million, up 35.85% from the prior year.
- Interest Expenses was $100000.0 for Q1 2026 at Eledon Pharmaceuticals, up from $99000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $990000.0 in Q1 2025 and bottomed at $83000.0 in Q1 2023.
- A 5-year average of $437176.5 and a median of $487000.0 in 2023 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses jumped 21500.0% — and 2026, when it tumbled 89.9%.
- Eledon Pharmaceuticals' Interest Expenses stood at $97000.0 in 2022, then advanced by 2.06% to $99000.0 in 2023, then gained by 7.07% to $106000.0 in 2024, then fell by 6.6% to $99000.0 in 2025, then rose by 1.01% to $100000.0 in 2026.
- Business Quant data shows ELDN's Interest Expenses at $100000.0 in Q1 2026, $99000.0 in Q4 2025, and $795000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Eledon Pharmaceuticals | 5.43 Mn | -105.66 Mn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 99,000.00 |
| Dec 31, 2025 | 99,000.00 |
| Sep 30, 2025 | 795,000.00 |
| Sep 30, 2025 | 795,000.00 |
| Jun 30, 2025 | 893,000.00 |
| Jun 30, 2025 | 893,000.00 |
| Mar 31, 2025 | 990,000.00 |
| Mar 31, 2025 | 990,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Dec 31, 2024 | 106,000.00 |
| Sep 30, 2024 | 571,000.00 |
| Sep 30, 2024 | 571,000.00 |
| Jun 30, 2024 | 673,000.00 |
| Jun 30, 2024 | 673,000.00 |
| Mar 31, 2024 | 287,000.00 |
| Mar 31, 2024 | 287,000.00 |
| Dec 31, 2023 | 99,000.00 |
| Dec 31, 2023 | 99,000.00 |